Ongoing
Closed
Clinical validation of an AI-based DEcision support system for Robotic upper limb rehabilitation in patients with Stroke. A CO-AIDER Study
Sat 1 Apr, 2023
A REAL-world, retrospective cohort study of the prevention of episodic or chronic migration in patients treated with galcanezumab at headache centers in ITalY: REALITY”.
Thu Dec 16, 2021
Randomized, double-blind, placebo-controlled clinical trial to evaluate the effect and safety of oral semaglutide in subjects with early Alzheimer's disease (EVOKE)
Fri 18th Sep 2020. p.m. CEST
Non-invasive gamma stimulation to counteract cognitive and neuropsychiatric symptoms in Mild Cognitive Impairment and Alzheimer's Disease.
Fri 18th Sep 2020. p.m. CEST
SPEECH MEDICAL REHABILITATION ASSOCIATED WITH VAGAL STIMULATION FOR THE TREATMENT OF DYSPHAGIA AFTER STROKE (LOGIC)
Fri 18th Sep 2020. p.m. CEST
Multicenter, randomized, double-blind, parallel-group, placebo-controlled study with an open-label period to evaluate the efficacy and safety of fremanezumab for the prophylactic treatment of migraine in patients with inadequate response to previous preventive treatments
Wed 9 May, 2018
Pharmacogenomics for predicting liver toxicity in multiple sclerosis patients treated with interferon beta
Mon Jan 1, 2018
Effect of calcifediol on seizure control in pharmacologically treated adult patients with epilepsy (EPID2020)
Fri 1th Sep 2017. p.m. CEST
A Prospective, Non-Interventional, Observational, Multicenter Study to Investigate Dosage, Effectiveness, and Safety of Perampanel when Used as First Adjunctive Therapy in the Routine Clinical Care of Subjects ≥12 Years with Partial Onset Seizures With or Without Secondary Generalization or with Primary Generalized Tonic–Clonic Seizures Associated with Idiopathic Generalized Epilepsy. Study E2007-M044-512
Fri 1th Sep 2017. p.m. CEST